Title |
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC |
---|---|
Involved |
Xu Zhou (Verfasser)
Jingyu An (Verfasser) Roman Kurilov (Verfasser) Benedikt Brors (Verfasser)
Kai Hu (Verfasser)
Teresa Peccerella (Verfasser) Stephanie Rössler (Verfasser) Katrin Pfütze (Verfasser) Angela Schulz (Verfasser) Stephan Wolf (Verfasser) Nicolas Hohmann (Verfasser) Dirk Theile (Verfasser) Max Sauter (Verfasser) Jürgen Burhenne (Verfasser) Shigenori Ei (Verfasser) Ulrike Heger (Verfasser) Oliver Strobel (Verfasser) Simon T. Barry (Verfasser) Christoph Springfeld (Verfasser) Christin Tjaden (Verfasser) Frank Bergmann (Verfasser) Markus W. Büchler (Verfasser) Thilo Hackert (Verfasser) Franco Fortunato (Verfasser) John P. Neoptolemos (Verfasser) Peter Bailey (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Nature cancer 4, 9, 7.9.2023, date:9.2023, Seite 1362-1381 |
Published |
2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Life Sciences. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2023121112192824692433 (URN) |
Record ID |
1312957573 |
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: